On November 16, 2022 Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) reported that it will hold an Investor and Analyst Day at The St. Regis New York on December 13, 2022, from 11:00 a.m. to 12:30 p.m. Eastern time (8:00 a.m. to 9:30 a.m. Pacific time) (Press release, Ligand, NOV 16, 2022, View Source [SID1234624151]). A live and archived webcast will be available for those unable to attend in person. Presenters will include:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Discussion of Ligand’s commitment to ESG and ongoing corporate sustainability initiatives
The presentations will be followed by lunch for those attending in person. The live and archived webcast can be accessed here. For more information or make a reservation to attend, please contact Carolyn Curran at [email protected].